NCT05324800 is a NA clinical trial of Curcuma Longa Extract Mixture in Immunity, sponsored by Chonbuk National University Hospital.

Who is sponsoring NCT05324800?

NCT05324800 is sponsored by Chonbuk National University Hospital.

What drugs are being tested in NCT05324800?

Interventions in NCT05324800: Curcuma Longa Extract Mixture, placebo group.

Is NCT05324800 still recruiting?

NCT05324800 is currently status unknown. Last updated 12 April 2022.

Last reviewed 2022-04-12 · How we verify

NCT05324800

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement

Status unknown NA Last updated 12 April 2022

What this trial tests

NA trial testing Curcuma Longa Extract Mixture in Immunity in 100 participants. Status unknown.

Timeline

4 February 2022

Primary endpoint
27 April 2022

27 May 2022

Quick facts

Lead sponsor	Chonbuk National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	100
Start date	4 February 2022
Primary completion	27 April 2022
Estimated completion	27 May 2022
Sites	1 location across South Korea

Drugs / interventions tested

Curcuma Longa Extract Mixture
placebo group

Conditions studied

Immunity — all drugs for Immunity →

Sponsor

Chonbuk National University Hospital

Who can join

Adults 19 to 75, any sex, with Immunity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate the efficacy and safety of Curcuma longa extract mixture on immune enhancement

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Immunity

Currently open trials in the same condition.

NCT07341750 — Effects of Bacillus Coagulans SNZ 1969 on Immune Health in Healthy School-aged Children · NA · recruiting
NCT06724185 — Effects of LP28 on Immunity Enhancement in the Elderly · NA · recruiting

Other Chonbuk National University Hospital trials

Trials by the same sponsor.

NCT05450939 — Characteristics of Signal Intensity Gradient in Subarachnoid Hemorrhage After Aneurysmal Rupture · unknown
NCT05190237 — the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. · NA · completed
NCT05495191 — Signal Intensity Gradient in Cerebral Arteries · completed
NCT04940910 — The Efficacy and Safety of Black Rice Bran Extract on Immune Enhancement · NA · unknown
NCT04930640 — The Efficacy and Safety of SGF200 on Immune Enhancement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05324800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chonbuk National University Hospital
Last refreshed: 12 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05324800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing